Peer Review reports
From: Oritavancin as sequential therapy for Gram-positive bloodstream infections
| Original Submission | ||
|---|---|---|
| 23 Jun 2023 | Submitted | Original manuscript |
| Resubmission - Version 2 | ||
| Submitted | Manuscript version 2 | |
| 16 Aug 2023 | Reviewed | Reviewer Report |
| 28 Aug 2023 | Reviewed | Reviewer Report |
| 30 Aug 2023 | Author responded | Author comments - Matthew A. Miller |
| Resubmission - Version 3 | ||
| 30 Aug 2023 | Submitted | Manuscript version 3 |
| 22 Sep 2023 | Reviewed | Reviewer Report |
| 10 Oct 2023 | Author responded | Author comments - Matthew A. Miller |
| Resubmission - Version 4 | ||
| 10 Oct 2023 | Submitted | Manuscript version 4 |
| 17 Oct 2023 | Reviewed | Reviewer Report |
| Resubmission - Version 5 | ||
| Submitted | Manuscript version 5 | |
| Publishing | ||
| 18 Oct 2023 | Editorially accepted | |
| 24 Jan 2024 | Article published | 10.1186/s12879-023-08725-8 |
You can find further information about peer review here.